GAMMAPLEX

This brand name is authorized in Austria, Estonia, Lithuania, United Kingdom, United States

Active ingredients

The drug GAMMAPLEX contains one active pharmaceutical ingredient (API):

1 Immunoglobulins, normal human, IV UNII 66Y330CJHS - HUMAN IMMUNOGLOBULIN G

Human normal immunoglobulin contains mainly immunoglobulin G (IgG) with a broad spectrum of antibodies against infectious agents. The mechanism of action in indications other than replacement therapy is not fully elucidated, but includes immunomodulatory effects. Read about Immunoglobulins, normal human, IV

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
GAMMAPLEX Solution for infusion	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J06BA02	Immunoglobulins, normal human, for intravascular adm.	J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BA Immunoglobulins, normal human
Discover more medicines within J06BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1735343, 1735354, 1735365
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 171990, 172005, 217143, 375648, 375650, 375652
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1089224, 1089225, 1089226
Country: US	FDA, National Drug Code	Identifier(s): 64208-8234, 64208-8235